The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $45.68

Today's change+0.28 +0.62%
Updated February 24 4:01 PM EST. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $45.68

Today's change+0.28 +0.62%
Updated February 24 4:01 PM EST. Delayed by at least 15 minutes.

Abbott Laboratories Hits New 100-day High

Abbott Laboratories closed up Friday by (U.S.)$0.28 or 0.62% to (U.S.)$45.68 and setting a new 100-day high. Over the last five days, shares have gained 2.22% and 18.93% year to date. Shares have underperformed the S&P 500 by 6.14% during the last year.

Key company metrics

  • Open(U.S.) $45.29
  • Previous close(U.S.) $45.40
  • High(U.S.) $45.68
  • Low(U.S.) $45.23
  • Bid / Ask-- / --
  • YTD % change+18.93%
  • Volume7,608,646
  • Average volume (10-day)7,773,306
  • Average volume (1-month)8,938,394
  • Average volume (3-month)9,058,812
  • 52-week range(U.S.) $36.76 to (U.S.) $45.79
  • Beta1.44
  • Trailing P/E63.80×
  • P/E 1 year forward18.63×
  • Forward PEG1.66×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.32%
  • Trailing EPS(U.S.) $0.72
Updated February 24 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX1.57%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,3335,3025,3334,885
Total other revenue--------
Total revenue5,3335,3025,3334,885
Gross profit3,0233,0173,0522,746
Total cost of revenue2,3102,2852,2812,139
Total operating expense4,3854,4054,5174,361
Selling / general / administrative1,6061,6181,7461,683
Research & development338352348379
Depreciation / amortization121140145144
Interest expense (income), net operating--------
Unusual expense (income)1010-316
Other operating expenses, total--------
Operating income948897816524
Interest income (expense), net non-operating-153-117-103-58
Gain (loss) on sale of assets--------
Other--------
Income before tax875-1797152
Income after tax765-35759956
Income tax, total110178116-54
Net income798-329615316
Total adjustments to net income--------
Net income before extra. items765-35759956
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items765-35759956
Inc. avail. to common incl. extra. items798-329615316
Diluted net income798-329615316
Dilution adjustment--000
Diluted weighted average shares1,4841,4761,4801,484
Diluted EPS excluding extraordinary itemsvalue per share0.52-0.240.400.04
Dividends per sharevalue per share0.260.260.260.26
Diluted normalized EPSvalue per share0.52-0.240.400.04